1. Home
  2. SONN vs KXIN Comparison

SONN vs KXIN Comparison

Compare SONN & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • KXIN
  • Stock Information
  • Founded
  • SONN N/A
  • KXIN 2015
  • Country
  • SONN United States
  • KXIN China
  • Employees
  • SONN N/A
  • KXIN N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • KXIN Retail-Auto Dealers and Gas Stations
  • Sector
  • SONN Health Care
  • KXIN Consumer Discretionary
  • Exchange
  • SONN Nasdaq
  • KXIN Nasdaq
  • Market Cap
  • SONN 3.3M
  • KXIN 3.0M
  • IPO Year
  • SONN N/A
  • KXIN N/A
  • Fundamental
  • Price
  • SONN $2.98
  • KXIN $2.12
  • Analyst Decision
  • SONN Strong Buy
  • KXIN
  • Analyst Count
  • SONN 3
  • KXIN 0
  • Target Price
  • SONN $117.33
  • KXIN N/A
  • AVG Volume (30 Days)
  • SONN 1.4M
  • KXIN 3.0M
  • Earning Date
  • SONN 12-12-2024
  • KXIN 01-01-0001
  • Dividend Yield
  • SONN N/A
  • KXIN N/A
  • EPS Growth
  • SONN N/A
  • KXIN N/A
  • EPS
  • SONN N/A
  • KXIN N/A
  • Revenue
  • SONN $55,881.00
  • KXIN $12,679,000.00
  • Revenue This Year
  • SONN N/A
  • KXIN N/A
  • Revenue Next Year
  • SONN N/A
  • KXIN N/A
  • P/E Ratio
  • SONN N/A
  • KXIN N/A
  • Revenue Growth
  • SONN N/A
  • KXIN N/A
  • 52 Week Low
  • SONN $2.50
  • KXIN $2.01
  • 52 Week High
  • SONN $18.72
  • KXIN $120.60
  • Technical
  • Relative Strength Index (RSI)
  • SONN 30.17
  • KXIN 36.75
  • Support Level
  • SONN $2.50
  • KXIN $2.28
  • Resistance Level
  • SONN $3.50
  • KXIN $2.73
  • Average True Range (ATR)
  • SONN 0.85
  • KXIN 0.76
  • MACD
  • SONN 0.00
  • KXIN 0.05
  • Stochastic Oscillator
  • SONN 6.38
  • KXIN 2.08

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Share on Social Networks: